Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Convolutional neural network to predict IDH mutation status in glioma from chemical exchange saturation transfer imaging at 7 Tesla

8 May 2023

Abstract excerpt

Background and goal: Noninvasive prediction of isocitrate dehydrogenase (IDH) mutation status in glioma guides surgical strategies and individualized management. We explored the capability on preoperatively identifying IDH status of combining a convolutional neural network (CNN) and a novel imaging modality, ultra-high field 7.0 Tesla (T) chemical exchange saturation transfer (CEST) imaging. Method: We enrolled...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatocellular Carcinoma Treatment and Prognosis
Share to MRI in cancer diagnosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37223677
DOI: 10.3389/fonc.2023.1134626

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Convolutional neural network to predict IDH mutation status in glioma from chemical exchange saturation transfer imaging at 7 TeslaPMID 37223677Read ↗

Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics.Semantic proximity Read ↗

Enhanced Glioma Genotype Prediction Using CEST MRI With Full Z-Spectrum Input, Pixel-Level Learning, and Majority Voting.Semantic proximity Read ↗

Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.Semantic proximity Read ↗

[A Dual-Aware deep learning framework for identification of glioma isocitrate dehydrogenase genotype using magnetic resonance amide proton transfer modalities].Semantic proximity Read ↗

An Intra- and Inter-Modality Fusion Model Using MR Images for Prediction of Glioma Isocitrate Dehydrogenase (IDH) Mutation.Semantic proximity Read ↗

Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI.Semantic proximity Read ↗

Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach.Semantic proximity Read ↗

A multimodal ConvNeXt-Tiny deep learning model for simultaneous prediction of IDH mutation and Ki-67 expression in gliomas.Semantic proximity Read ↗

CEST MRI Provides Amides/amines Surrogate Biomarkers for Treatment-naïve Glioma Sub-typingSemantic proximity Read ↗

7 Tesla magnetic resonance spectroscopic imaging predicting IDH status and glioma grading.Semantic proximity Read ↗

Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural networkSemantic proximity Read ↗

Diagnostic performance between MR amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in glioma grading and IDH mutation status prediction at 3 T.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.